Literature DB >> 1717632

Antigen-driven bystander suppression after oral administration of antigens.

A Miller1, O Lider, H L Weiner.   

Abstract

Suppression of experimental autoimmune encephalomyelitis (EAE) in Lewis rats by the oral administration of myelin basic protein (MBP) is mediated by CD8+ T cells that can be isolated from the spleens of MBP-fed animals. These cells adoptively transfer protection to naive animals subsequently immunized with MBP and complete Freund's adjuvant (CFA) and suppress in vitro MBP proliferative responses. Using a transwell system in which the modulator spleen cells from MBP-fed animals are separated by a semipermeable membrane from responder cells, MBP, or OVA-specific T cell lines, we have found that cell contact is not required for in vitro suppression to occur. In vitro suppression is dependent, however, upon antigen-specific triggering of modulator T cells. Once antigen-specific triggering occurs, suppression across the transwell is mediated by an antigen-nonspecific soluble factor that equally suppresses an MBP line or an ovalbumin (OVA) line. This phenomenon of antigen-driven bystander suppression was also demonstrated in vivo. Specifically, Lewis rats fed OVA which were then immunized with MBP/CFA plus OVA given separately subcutaneously were protected from EAE. Animals fed OVA and then immunized with MBP/CFA without OVA given subcutaneously were not protected. The protective effect of feeding OVA could be adoptively transferred by CD8+ T cells from OVA-fed animals into MBP/CFA plus OVA-injected animals. Feeding bovine serum albumin (BSA) or keyhole limpet hemocyanin did not suppress EAE in animals immunized with MBP/CFA plus OVA. EAE was suppressed, however, if BSA was fed and animals then immunized with MBP/CFA plus BSA given subcutaneously. Antigen-driven bystander suppression appears to be an important mechanism by which antigen-driven peripheral tolerance after oral administration of antigen is mediated, and presumably occurs in the microenvironment accounting for the antigen specificity of suppression generated by oral tolerization to antigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717632      PMCID: PMC2118953          DOI: 10.1084/jem.174.4.791

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

Review 1.  Suppressor cells and immunoregulation.

Authors:  M E Dorf; B Benacerraf
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

2.  Present understanding of suppressor T cells.

Authors:  T Tada; Y Asano; K Sano
Journal:  Res Immunol       Date:  1989 Mar-Apr

3.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T cells.

Authors:  A M Gautam; P Glynn
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

5.  Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.

Authors:  R B Nussenblatt; R R Caspi; R Mahdi; C C Chan; F Roberge; O Lider; H L Weiner
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

6.  Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.

Authors:  H S Thompson; N A Staines
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

7.  Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

Authors:  C Nagler-Anderson; L A Bober; M E Robinson; G W Siskind; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis.

Authors:  S Sriram; G Schwartz; L Steinman
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

Review 9.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09

10.  Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.

Authors:  H G Rammensee; R Kroschewski; B Frangoulis
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

View more
  96 in total

Review 1.  Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 2.  T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.

Authors:  G F Hoyne; M J Dallman; J R Lamb
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 3.  Oral tolerance and gut-oriented immune response to dietary proteins.

Authors:  O Alpan
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 4.  Probiotics and immune response.

Authors:  Stephanie Blum; Dirk Haller; Andrea Pfeifer; Eduardo J Schiffrin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

5.  Oral administration of antigen does not influence the proliferation and IFN-γ production of responsive CD8+ T cells but enables to establish T cell clones with different lymphokine production profile.

Authors:  K Nishijima; T Hisatsune; H Kato; M Kohyama; M Kakehi; S Hachimura; S Kaminogawa
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

Review 6.  The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes.

Authors:  Jean-François Bach; Lucienne Chatenoud
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

7.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.

Authors:  H Fukaura; S C Kent; M J Pietrusewicz; S J Khoury; H L Weiner; D A Hafler
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

8.  A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens.

Authors:  L B Nicholson; A Murtaza; B P Hafler; A Sette; V K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

9.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

10.  Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.

Authors:  T Bárdos; M Czipri; C Vermes; J Zhang; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.